AVAVA MIRIA General Use (NCT06868615) | Clinical Trial Compass
RecruitingNot Applicable
AVAVA MIRIA General Use
United States200 participantsStarted 2024-09-11
Plain-language summary
A general protocol to treat a variety of dermatologic conditions and collect patient feedback.
Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in regards to improvement seen in the device as well as assessment of side effects.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Male or female subjects between 18 to 70 years of age.
✓. Dermatologic condition that can be addressed by the laser, including but not limited to:
✓. Wrinkles
✓. Scars
✓. Acne Scars
✓. Active Acne
✓. Dyschromia
✓. Cutaneous Lesions such as Age or Sun Spots
Exclusion criteria
✕. Skin pathology or condition that could interfere with evaluation of the study procedure, e.g.,
✕. Systemic treatment prescribed within previous 6 months (e.g., oral medication such as isotretinoin)
✕. Surgical treatment in the target areas within previous 6 months (e.g., laser surgery)
✕. Active vitiligo, psoriasis, or eczema in the treatment area
✕. Injection of dermal filler in the target areas within previous 1 month (e.g., collagen, hyaluronic acid filler)
✕. Cosmetic procedures in the target areas within prior 3 months (e.g., laser, microdermabrasion, skin peel)
What they're measuring
1
Completion of Post-Treatment Subject Questionnaire